circadian rhythm raises a handful of sensible questions. This page answers them in order, starting with the fundamentals and moving to applications.
Reviewed 2026-02-04. Anything still debated is marked as such rather than presented as settled.
Laboratory samples of SR9009 are typically handled as research chemicals rather than pharmaceuticals. Suppliers usually state that the material is for research use only and not for human or veterinary administration. Storage recommendations generally call for a freezer at approximately −20 °C, protection from light, and a desiccated environment. The solid is often described as a white to off-white powder. Solubility is commonly reported in organic solvents such as dimethyl sulfoxide and ethanol, with low solubility in water.
Analytical identification and purity assessment often use high-performance liquid chromatography with ultraviolet detection or mass spectrometry. Liquid chromatography–tandem mass spectrometry is used to detect and quantify SR9009 in biological matrices, including urine and blood, for anti-doping or pharmacokinetic studies. Nuclear magnetic resonance spectroscopy can confirm molecular structure. Stability depends on form and storage: the solid is generally more stable than solutions, and repeated freeze–thaw cycles may degrade samples. Purity is typically reported as a percentage from a certificate of analysis.
SR9009 is a synthetic small molecule studied as a REV-ERB agonist. REV-ERBα and REV-ERBβ are nuclear receptors that help regulate circadian rhythms and metabolic gene expression. The compound was identified in academic screening efforts to find synthetic ligands for these receptors. In cell and animal studies, SR9009 alters transcription of genes involved in lipid and glucose metabolism, and it can shift circadian behavior. It is not an approved therapeutic agent.
Mechanistically, SR9009 binds the ligand-binding domain of REV-ERBα/β and enhances recruitment of corepressor complexes. This represses target genes rather than activating them. Because REV-ERB proteins normally compete with ROR proteins at shared response elements, the net effect depends on tissue and timing. Researchers use SR9009 to probe how nuclear receptor signaling links the clock to metabolism, inflammation, and muscle biology. Findings are largely preclinical, and the precise contribution of each receptor subtype remains under study.
SR9009 is frequently discussed in fitness and research-chemical contexts, yet it has no approved medical indication. Regulatory agencies have not authorized it for human use, and it is not a standard prescription drug. Some sports organizations list it as a prohibited substance because of its potential performance-enhancing properties. Published human data are sparse, so claims about its effects in people often rely on animal models or anecdotal reports. Quality and identity of online materials can vary widely.
| Property | Value | Notes |
|---|---|---|
| Appearance | White to off-white powder | Common supplier description |
| Solubility | Soluble in DMSO and ethanol | Low solubility in water |
| Typical storage | −20 °C, desiccated, dark | For research samples |
| Analytical method | LC-MS/MS | Used for detection and quantification |
| Regulatory status | Prohibited in sport | WADA metabolic modulator class |
Storage recommendations for SR9009 reference material typically specify a freezer at -20 °C or lower, with protection from moisture and light. Repeated freeze-thaw cycles can degrade small molecules and introduce variability. Stock solutions in dimethyl sulfoxide are often aliquoted to avoid repeated handling. Stability studies may examine degradation under heat, humidity, and light exposure. The compound's thiophene and nitro groups can participate in reactions that alter analytical signals over time, so such changes affect quantitative results.
Quality control for research materials includes identity confirmation by nuclear magnetic resonance and purity assessment by high-performance liquid chromatography. Mass spectrometry provides molecular weight confirmation and can detect related impurities. Purchasers should request a certificate of analysis that lists lot-specific data. Online products advertised for human use often lack such documentation. Distinguishing legitimate research material from mislabeled or contaminated samples is a recurring challenge in independent testing, and independent laboratories may use orthogonal methods to verify identity.
=== Substrate binding === Creatine binds inside the β-half-barrel trough of the large C-terminal domain, forming hydrogen bonds between its amidino and carboxyl groups and the enzyme's amino-acid residues. A metal ion, either Zn2+ or Mn2+, is used to stabilize the substrate and polarize the amidino group.
== Career == Macor began his industrial career at Pfizer in 1986, where he was a co-inventor of eletriptan, a triptan marketed as Relpax for the acute treatment of migraine. Eletriptan was approved by the FDA in 2002. He later joined Bristol-Myers Squibb in 1997, where he served as executive director of neuroscience chemistry. At Bristol-Myers Squibb, he was a co-inventor in the program that produced the CGRP receptor antagonists rimegepant and zavegepant, which were subsequently developed by Biohaven Pharmaceuticals and approved by the FDA in 2020 and 2023, respectively, for the treatment of migraine. He is also a co-inventor of sparsentan, a dual endothelin and angiotensin II receptor antagonist developed by Travere Therapeutics and approved by the FDA in 2023 for the reduction of proteinuria in adults with IgA nephropathy. Macor’s work at Bristol-Myers Squibb also included the company’s Alzheimer’s disease program, where he contributed to the discovery of avagacestat (BMS-708163), a γ-secretase inhibitor that advanced to Phase 2 clinical trials before development was discontinued. Macor is an author on more than 220 peer-reviewed publications and a named inventor on 150 issued U.S. patents.
Fungal proteins, including algal-binding proteins, may mediate this selection by recognizing compatible photobionts. These proteins interact specifically with Trebouxia cell walls, suggesting a biochemical mechanism for partner recognition. Bubrick and Galun (1980) identified a protein in X. parietina that binds selectively to the cell walls of its cultured photobiont, with binding strength correlating with acidic polysaccharide levels. This interaction may be crucial during lichen resynthesis, as X. parietina propagates via fungal spores and must recruit new photobionts from the environment. Live-cell imaging has revealed a dynamic mitochondrial network (chondriome) in Trebouxia freshly isolated from X. parietina. The findings suggest that mitochondria may be shaped by the lichenized state and contribute to energy exchange with the fungal partner. They also appear to play a role in stress responses, such as desiccation tolerance, typically studied in relation to the chloroplast. These insights may help clarify physiological interactions in lichen symbiosis.
Sources: en.wikipedia.org
=== Anabolic hormones === Endocrinologists have traditionally classified hormones as anabolic or catabolic, depending on which part of metabolism they stimulate. The classic anabolic hormones are the anabolic steroids, which stimulate protein synthesis and muscle growth, and especially insulin, which is the main anabolic hormone of the body, regulating the metabolism of protein, carbohydrates, and fats.
. Thus, the rule of conservation of energy over time in special relativity continues to hold, so long as the reference frame of the observer is unchanged. This applies to the total energy of systems, although different observers disagree as to the energy value. Also conserved, and invariant to all observers, is the invariant mass, which is the minimal system mass and energy that can be seen by any observer, and which is defined by the energy–momentum relation.
Antigen-naive T cells expand and differentiate into memory and effector T cells after they encounter their cognate antigen within the context of an MHC molecule on the surface of a professional antigen presenting cell (e.g. a dendritic cell). Appropriate co-stimulation must be present at the time of antigen encounter for this process to occur. Historically, memory T cells were thought to belong to either the effector or central memory subtypes, each with their own distinguishing set of cell surface markers (see below). Subsequently, numerous new populations of memory T cells were discovered including tissue-resident memory T (Trm) cells, stem memory TSCM cells, and virtual memory T cells. The single unifying theme for all memory T cell subtypes is that they are long-lived and can quickly expand to large numbers of effector T cells upon re-exposure to their cognate antigen. By this mechanism they provide the immune system with "memory" against previously encountered pathogens. Memory T cells may be either CD4+ or CD8+ and usually express CD45RO. Memory T cell subtypes:
In particular, decreased access to public health services such as syringe exchange programs and confiscation of syringes can precipitate a cascade of health harms. Geographic diffusion of epidemics from the northern border states elsewhere is also possible with the rotation of police and military personnel stationed in drug conflict areas with high infection prevalence. With increased drug use, there has been a parallel rise in demand for drug user treatment in Mexico.
Sources: en.wikipedia.org
=== Pharmacokinetics === Little formal knowledge exists on 5-MAPB. It does not form the α-methyldopamine metabolite that contributes to the neurotoxicity of MDMA or MDA. A study in rats indicated that the major metabolites of 5-MAPB are 5-APB and 3-carboxymethyl-4-hydroxymethamphetamine.
== Music video == The shoot for the music video was released on YouTube on September 30 by Mike & Rocco (reality). The video was set to premiere on January 5, 2009 but leaked on December 31, 2008 and was officially released on January 1, 2009 via MTV Jams.
=== Domestic expansion === Their success encouraged the Murrells to franchise their concept the following year, engaging Fransmart, a franchise sales organization. Former American football player Mark Moseley, who had gone to work for Fransmart after his football career, played a key role in Five Guys' expansion and went on to become the company's director of franchise development after it ended its business relationship with Fransmart. In early 2003, the chain began franchising, opening the doors to rapid expansion which caught the attention of national restaurant trade organizations and the national press. The expansion started in Virginia and Maryland, and by the end of 2004, over 300 units were in development through the Northeast. Over the next few years, the chain rapidly expanded across the entire United States and into Canada, reaching over 1,000 locations by 2012. Five Guys Enterprises has several affiliated companies that are not part of a consolidated group, but are under common ownership. Five Guys Operations was founded in 2012, Five Guys Holdings was founded in 2007. Five Guys Foods UK Limited was incorporated on March 12, 2013. FGE International, FGO International BV, and FG Coöperatief U.A. are based in Amsterdam. FGH International C.V. is located in Bermuda. Five Guys had a 39,900-square-foot (3,710 m2) headquarters in Lorton, Virginia, overlooking the Occoquan and Potomac Rivers, that was specially designed to convey the corporate brand.
=== Wnt signaling === In 2012, Garcia's laboratory determined the crystal structure of a Wnt protein in complex with its cellular receptor, Frizzled. The Wnt-Frizzled structure indicated that Wnts utilize a post-translational lipid modification to directly engage the Frizzled extracellular domain, which represents a highly unusual binding mode among soluble ligands. Garcia's study revealed a striking, donut-shaped architecture adopted by the Wnt-Frizzled complex that adorns the cover of the July 6th, 2012 issue of Science. More recently, Garcia's laboratory reported a breakthrough in being able to recapitulate canonical Wnt signaling using water-soluble bispecific ligands that dimerize Frizzled and Lrp6, which has important implications for the development of therapeutics for regenerative medicine.
== Blood doping == Blood doping is the injection of red blood cells, related blood products that contain red blood cells, or artificial oxygen containers. This is done by extracting and storing one's own blood prior to an athletic competition, well in advance of the competition so that the body can replenish its natural levels of red blood cells, and subsequently injecting the stored blood immediately before competition. The resulting unnatural level of red blood cells improves oxygen transport and athletic endurance; thus, it is prohibited in most events. It is often used in extreme sports like cycling, snowboarding, and skiing where endurance is highly valued. The most famous example of this type of doping is Lance Armstrong's performance in the Tour de France.
Sources: en.wikipedia.org
Legality depends on the country and the intended use. In many places it is sold as a research chemical, but sports and medicine regulations restrict it.
Detection commonly uses liquid chromatography–tandem mass spectrometry. This method can identify the compound in urine or blood at low concentrations.
Typical guidance is −20 °C, dry, and protected from light. Solutions should be aliquoted and limited freeze–thaw cycles should be used.
SR9009 is a synthetic compound investigated as an agonist of the nuclear receptors REV-ERBα and REV-ERBβ. It is used in preclinical research on circadian rhythm and metabolism. It is not an approved drug.